124 related articles for article (PubMed ID: 9462431)
1. Association of resistance to trimethoprim/sulphamethoxazole, chloramphenicol and quinolones with changes in major outer membrane proteins and lipopolysaccharide in Burkholderia cepacia.
Rajyaguru JM; Muszynski MJ
J Antimicrob Chemother; 1997 Dec; 40(6):803-9. PubMed ID: 9462431
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of Burkholderia cepacia antimicrobial susceptibility by cationic compounds.
Rajyaguru JM; Muszynski MJ
J Antimicrob Chemother; 1997 Sep; 40(3):345-51. PubMed ID: 9338485
[TBL] [Abstract][Full Text] [Related]
3. Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein.
Burns JL; Clark DK
Antimicrob Agents Chemother; 1992 Oct; 36(10):2280-5. PubMed ID: 1280056
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance.
Burns JL; Wadsworth CD; Barry JJ; Goodall CP
Antimicrob Agents Chemother; 1996 Feb; 40(2):307-13. PubMed ID: 8834871
[TBL] [Abstract][Full Text] [Related]
5. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of antimicrobial agents, alone and in combinations, against Burkholderia cepacia isolated from blood.
Lu DC; Chang SC; Chen YC; Luh KT; Hsieh WC
Diagn Microbiol Infect Dis; 1997 Aug; 28(4):187-91. PubMed ID: 9327247
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance patterns and SDS-PAGE protein profiles of Burkholderia cepacia complex isolates from nosocomial and environmental sources in Venezuela.
Araque-Calderon Y; Miranda-Contreras L; Rodriguez-Lemoine V; Palacios-Pru EL
Med Sci Monit; 2008 Feb; 14(2):BR49-55. PubMed ID: 18227759
[TBL] [Abstract][Full Text] [Related]
8. Outer membrane permeability in Pseudomonas cepacia: diminished porin content in a beta-lactam-resistant mutant and in resistant cystic fibrosis isolates.
Aronoff SC
Antimicrob Agents Chemother; 1988 Nov; 32(11):1636-9. PubMed ID: 2855296
[TBL] [Abstract][Full Text] [Related]
9. [Drug-resistance patterns of clinical isolates of Pseudomonas aeruginosa in regard to their lipopolysaccharide-chain sizes].
Hasegawa M; Kobayashi I; Saika T; Nishida M
Kansenshogaku Zasshi; 1996 Jun; 70(6):605-12. PubMed ID: 8741710
[TBL] [Abstract][Full Text] [Related]
10. Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.
Manno G; Ugolotti E; Belli ML; Fenu ML; Romano L; Cruciani M
Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):28-34. PubMed ID: 12582741
[TBL] [Abstract][Full Text] [Related]
11. Outer membrane vesicles produced by
Kim SY; Kim MH; Son JH; Kim SI; Yun SH; Kim K; Kim S; Shin M; Lee JC
Virulence; 2020 Dec; 11(1):995-1005. PubMed ID: 32799627
[TBL] [Abstract][Full Text] [Related]
12. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
Bernier SP; Son S; Surette MG
J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
[TBL] [Abstract][Full Text] [Related]
13. Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis.
Simpson IN; Finlay J; Winstanley DJ; Dewhurst N; Nelson JW; Butler SL; Govan JR
J Antimicrob Chemother; 1994 Sep; 34(3):353-61. PubMed ID: 7530242
[TBL] [Abstract][Full Text] [Related]
14. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
Kumar A; Hay MB; Maier GA; Dyke JW
J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
[TBL] [Abstract][Full Text] [Related]
15. Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia.
Albrecht MT; Wang W; Shamova O; Lehrer RI; Schiller NL
Respir Res; 2002; 3(1):18. PubMed ID: 11980587
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients with Burkholderia cepacia bacteremia.
Huang CH; Jang TN; Liu CY; Fung CP; Yu KW; Wong WW
J Microbiol Immunol Infect; 2001 Sep; 34(3):215-9. PubMed ID: 11605815
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas cepacia: the sensitivity of nosocomial strains to new antibiotics.
Santos Ferreira MO; Canica MM; Bacelar MJ
J Int Med Res; 1985; 13(5):270-5. PubMed ID: 3902532
[TBL] [Abstract][Full Text] [Related]
18. Serum IgG response to Burkholderia cepacia outer membrane antigens in cystic fibrosis: assessment of cross-reactivity with Pseudomonas aeruginosa.
Lacy DE; Smith AW; Stableforth DE; Smith G; Weller PH; Brown MR
FEMS Immunol Med Microbiol; 1995 Feb; 10(3-4):253-61. PubMed ID: 7539670
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates.
Saika T; Kobayashi I; Hasegawa M; Nishida M
J Infect Chemother; 2002 Dec; 8(4):341-4. PubMed ID: 12525895
[TBL] [Abstract][Full Text] [Related]
20. Effect of pH and CO2 on in vitro susceptibility of Pseudomonas cepacia to beta-lactams.
Corkill JE; Deveney J; Pratt J; Shears P; Smyth A; Heaf D; Hart CA
Pediatr Res; 1994 Mar; 35(3):299-302. PubMed ID: 7514780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
